The tolerability of the capsule regimen was rated “not difficult
at all” in 20 and 19 patients in the fish oil and placebo groups,
respectively; “slightly difficult” in eight and eight patients,
respectively; “moderately difficult” in two and three patients,
respectively; and “extremely difficult” in no patients. More
patients in the fish oil group than in the placebo group experienced
new symptoms (Table 3). No bleeding episodes, severe
infections, or cases of symptomatic hyperglycemia attributed to
the treatment were observed.